Brachyspira and Intestinal Allergy-like Immune Reactions in Patients With Irritable Bowel Syndrome (IBS)
NCT06413004 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2024-05-14
Summary
The aim of this study is to define local immune responses in the GI tract to food antigens in IBS patients, with and without Brachyspira infection, using advanced imaging. We hypothesize that Brachyspira infection can cause IBS symptoms by inducing loss of oral tolerance to dietary antigens through development of food-specific intestinal immune reactions and subsequent development of visceral hypersensitivity.
During this study, the investigators will perform either confocal laser endomiscroscopy (CLE) or colonoscopic antigen provocation test (COLAP) to test to which food items the participants react to. Furthermore, the investigators will perform rectal barostat examination and a sigmoidoscopy without laxatives. The investigators will collect biological samples and the participants will complete several questionnaires.
Conditions
- Irritable Bowel Syndrome
- Food Sensitivity
Interventions
- OTHER
-
Elimination and re-introduction of CLE or COLAP positive food item(s)
Elimination (4 weeks) and re-introduction (4 weeks) of all CLE or COLAP positive food item(s)
Sponsors & Collaborators
-
Magnus Simrén
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-08-03
- Primary Completion
- 2027-01-01
- Completion
- 2027-01-01
Countries
- Sweden
Study Locations
More Related Trials
-
Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative Colitis
NCT00073047 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC)
NCT00307827 ·Status: TERMINATED ·Phase: PHASE2
-
Basiliximab in Moderate to Severe Ulcerative Colitis
NCT00430898 ·Status: COMPLETED ·Phase: PHASE2
-
Quantitative Assessment of Intestinal Motility on Bowel Ultrasound in Patients With Inflammatory Bowel Disease: a Feasibility, Observational, Cross-sectional, Monocentric Study
NCT05719402 ·Status: UNKNOWN
-
Evaluation of Molecular Mechanisms of Non-response to Therapy in Patients With Inflammatory Bowel Disease
NCT05733845 ·Status: RECRUITING ·Phase: NA
-
the Prevalence of Chronic Rhinosinusitis Associated With Inflammatory Bowel Disease and Association With Biomarkers of Epithelial Barrier Damage
NCT06149949 ·Status: NOT_YET_RECRUITING
-
The Altitude Inflammatory Bowel Disease Study
NCT02849821 ·Status: UNKNOWN ·Phase: NA
-
Study Comparing Cyclosporine With Infliximab in Steroid-refractory Severe Attacks of Ulcerative Colitis
NCT00542152 ·Status: COMPLETED ·Phase: PHASE4
-
Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis
NCT01294410 ·Status: COMPLETED ·Phase: PHASE2
-
Natural History of Intestinal Inflammation in People With Primary Immune Dysregulations
NCT03278912 ·Status: WITHDRAWN
-
Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease
NCT00032799 ·Status: COMPLETED ·Phase: PHASE3
-
The Use of Small Bowel Ultrasound to Predict Response to Remicade Induction
NCT02488005 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease
NCT00032786 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis
NCT00279422 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Characterization of the Intestinal Microbiota in Patients With Inflammatory Bowel Disease and/or Spondyloarthritis and Study of the Impact of an Anti-TNF Alpha Therapy
NCT03359642 ·Status: COMPLETED ·Phase: NA
-
Defining Predictors of RT Response to Vedolizumab in IBD
NCT03142321 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of Anorectal Function in Patients With Inflammatory Bowel Disease
NCT05185609 ·Status: RECRUITING
-
Autoimmune Gastrointestinal Dysmotility: Symptoms, Pathogenesis and Treatment
NCT04859829 ·Status: TERMINATED
-
A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease
NCT00606346 ·Status: ACTIVE_NOT_RECRUITING
-
Efficacy, Safety and Tolerability of Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis
NCT01538251 ·Status: TERMINATED ·Phase: PHASE3
-
Ocular Manifestations of Inflammatory Bowel Disease
NCT04771039 ·Status: COMPLETED
-
Visceral Sensitivity in IBD (Irritable Bowel Disease) and IBS (Irritable Bowel Syndrome)
NCT02421705 ·Status: RECRUITING ·Phase: NA
-
Superdonor FMT in Patients With Ulcerative Colitis
NCT05739864 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis
NCT03093259 ·Status: COMPLETED ·Phase: PHASE2
-
Autoimmune Protocol Diet and Inflammatory Bowel Disease
NCT03512327 ·Status: COMPLETED ·Phase: NA